OM Outset Medical, Inc.
USHealthcareAs of 2026-07-08 16:00
Why OM matters now
Outset Medical, Inc. (OM) is a US stock in Healthcare. The latest InvestLog snapshot shows $4.30 with -10.23% on the session and $79.7M in market capitalization; recent performance reads 1-month +30.83% and YTD +36.12%.
The latest financial table shown here is Q1 2026, with revenue of $27.9M, net income of $-19.0M, and EPS of $-1.03. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -36.6%.
The latest indexable market news headline is "Outset Medical, Inc. (NASDAQ: OM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements, Over $50 Million in Insider Sales" from PRNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $11.50; recent insider activity includes Drexler Karen filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.83
P/S
0.80
EV/EBITDA
-2.64
DCF Value
$-68.15
FCF Yield
-36.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
40.6%
Operating Margin
-56.9%
Net Margin
-63.7%
ROE
-55.9%
ROA
-30.0%
ROIC
-31.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $27.9M | $-19.0M | $-1.03 |
| Q4 2025 | $28.9M | $-19.5M | $-1.09 |
| FY 2025 | $119.5M | $-81.7M | $-5.37 |
| Q3 2025 | $29.4M | $-17.8M | $-1.00 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$11.50
Target (Median)
$11.50
Target Range
$8.00 - $15.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.94
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.